0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Product Request Form

Ofatumumab is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.

Name:
Email:

*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Ofatumumab:

  • Albania
  • Algeria
  • Anguilla
  • Argentina
  • Aruba
  • Austria
  • Bosnia and Herzegovina
  • Colombia
  • El Salvador
  • Estonia
  • France
  • Gibraltar
  • Greenland
  • Guam
  • Iceland
  • India
  • Indonesia
  • Iran
  • Jordan
  • Korea, South
  • Latvia
  • Lebanon
  • Mauritius
  • Monaco
  • Morocco
  • Panama
  • Paraguay
  • Peru
  • Poland
  • Qatar
  • Russian Federation
  • Saint Lucia
  • Saudi Arabia
  • Sweden
  • Switzerland
  • Thailand
  • United Kingdom, UK
  • United States, US
  • Vanuatu
  • Yemen
View All Countries

Latest news releases on Ofatumumab:

http://www.genmab.com/product-pipeline/products-in-development/ofatumumab

Vi ville gerne vise dig en beskrivelse her, men det websted, du kigger på, tillader det ikke.

Ofatumumab (Arzerra) Multiple Sclerosis | MS News Today

Ofatumumab (Arzerra) is an approved leukemia treatment marketed by Novartis and now in Phase 3 clinical tests for relapsing MS.

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab ...

The purpose of the study is to evaluate whether treatment with ibrutinib as a monotherapy results in a clinically significant improvement in progression free survival ...

A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients ...

This is an open-label, two- arm, randomized phase 3, superiority trial designed to evaluate the efficacy and safety of IPI-145 compared to ofatumumab administered to ...

Novartis Global Pipeline | Novartis

Discover the Novartis pipeline of over 200 projects in clinical development, many for medicines that could advance treatment standards for patients.

Cancer immunotherapy - Wikipedia

Cancer immunotherapy (sometimes called immuno-oncology, abbreviated IO) is the use of the immune system to treat cancer. Immunotherapies can be categorized as active ...

Mitomycyna – Wikipedia, wolna encyklopedia

Wskazania. Chemioterapia wielolekowa raka żołądka, raka sutka, raka płuca, raka pęcherza moczowego, raka szyjki macicy i nowotworów głowy i szyi. Możliwe ...

Rituximab - Wikipedia

Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin's ...

Roztroušená skleróza • Novinky a diskuse o vývoji ...

Novinky - Roztroušená skleróza - Nové a budoucí léky a léčebné metody pro roztroušenou sklerózu. Nejnovější zprávy z výzkumu.

YURTDIŞI İLAÇ FİYAT LİSTESİ (EK-4/C) EŞDEĞER ...

yurtdiŞi İlaÇ fİyat lİstesİ (ek-4/c) barkod İlacin adi etken madde 1111111100808 abraxane 100 mg 1 ampul paklitaksel i358a 290.00 € 1111111100003 acadion 250 ...

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2018 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK